Ginseng, the 'immunity boost': The effects of panax ginseng on immune system

Journal of Ginseng Research

Volumn 36, Issue 4, 2012, Pages 354-368

  Kang, Soowon ^a   Min, Hyeyoung ^a  

^a Chung Ang University   (South Korea)

Author keywords

Acquired immunity; Cytokine; Immunomodulation; Innate immunity; Panax ginseng

Indexed keywords

EID: 84867685659     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.4.354     Document Type: Review

References (121)

1. Akerele O. WHO guideline for assessment of herbal medicines. Fitoterapia 1992;63:99-104.
2. Baek SH, Bae ON, Park JH. Recent methodology in ginseng analysis. J Ginseng Res 2012;36:119-134.
3. Kim MK, Lee JW, Lee KY, Yang DC. Microbial conversion of major ginsenoside Rb1 to pharmaceutically active minor ginsenoside Rd. J Microbiol 2005;43:456-462.
4. Cui J, Garle M, Eneroth P, Bjorkhem I. What do commercial ginseng preparations contain? Lancet 1994;344:134.
5. Sohn EH, Jang SA, Lee CH, Jang KH, Kang SC, Park HJ, Pyo SN. Effects of Korean red ginseng extract for the treatment of atopic dermatitis-like skin lesions in mice. J Ginseng Res 2011;35:479-486.
6. Bae EA, Park SY, Kim DH. Constitutive beta-glucosi-dases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485.
7. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984;15:386-391.
8. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990;16:537-542.
9. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-1118.
10. Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000;3:473-485.
11. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol 2007;29:3-14.
12. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997;9:4-9.
13. Albiger B, Dahlberg S, Henriques-Normark B, Normark S. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J Intern Med 2007;261:511-528.
14. Gordon S. The macrophage. Bioessays 1995;17:977-986.
15. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003;54:469-487.
16. Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, Pyo S. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immuno-pharmacol Immunotoxicol 2002;24:469-482.
17. Lim DS, Bae KG, Jung IS, Kim CH, Yun YS, Song JY. Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation. J Infect 2002;45:32-38.
18. Choi HS, Kim KH, Sohn E, Park JD, Kim BO, Moon EY, Rhee DK, Pyo S. Red ginseng acidic polysaccha-ride (RGAP) in combination with IFN-gamma results in enhanced macrophage function through activation of the NF-kappaB pathway. Biosci Biotechnol Biochem 2008;72:1817-1825.
19. Friedl R, Moeslinger T, Kopp B, Spieckermann PG. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol 2001;134:1663-1670.
20. Wang H, Actor JK, Indrigo J, Olsen M, Dasgupta A. Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. Clin Chim Acta 2003;327:123-128.
21. Palucka K, Banchereau J. Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 1999;19:12-25.
22. Stockwin LH, McGonagle D, Martin IG, Blair GE. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol Cell Biol 2000;78:91-102.
23. Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, Shin T, Joo HG. Immunomodulatory activity of ginsan, a polysac-charide of Panax ginseng, on dendritic cells. Korean J Physiol Pharmacol 2009;13:169-173.
24. Takei M, Tachikawa E, Hasegawa H, Lee JJ. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem Pharmacol 2004;68:441-452.
25. Su W, Sun AJ, Xu DL, Zhang HQ, Yang L, Yuan LY, Jia JG, Zou YZ, Wu YL, Wang KQ et al. Inhibiting effects of total saponins of Panax ginseng on immune maturation of dendritic cells induced by oxidized-low density lipoprotein. Cell Immunol 2010;263:99-104.
26. Tung NH, Quang TH, Son JH, Koo JE, Hong HJ, Koh YS, Song GY, Kim YH. Inhibitory effect of ginsenosides from steamed ginseng-leaves and flowers on the LPS-stimulated IL-12 production in bone marrow-derived dendritic cells. Arch Pharm Res 2011;34:681-685.
27. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004;306:1517-1519.
28. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 1990;54:447-454.
29. Kim JY, Germolec DR, Luster MI. Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 1990;12:257-276.
30. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodefi ciency syndrome patients. Immunopharmacology 1997;35:229-235.
31. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-291.
32. Kurtz J. Memory in the innate and adaptive immune systems. Microbes Infect 2004;6:1410-1417.
33. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998;8:363-372.
34. Newton SM, Jacob CO, Stocker BA. Immune response to cholera toxin epitope inserted in Salmonella fl agellin. Science 1989;244:70-72.
35. Vecchiarelli A, Casadevall A. Antibody-mediated effects against Cryptococcus neoformans: evidence for interde-pendency and collaboration between humoral and cellular immunity. Res Immunol 1998;149:321-333.
36. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010;20:34-50.
37. Liou CJ, Huang WC, Tseng J. Long-term oral administration of ginseng extract modulates humoral immune response and spleen cell functions. Am J Chin Med 2005;33:651-661.
38. Liou CJ, Li ML, Tseng J. Intraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in mice. Am J Chin Med 2004;32:75-88.
39. Na HS, Lim YJ, Yun YS, Kweon MN, Lee HC. Ginsan enhances humoral antibody response to orally delivered antigen. Immune Netw 2010;10:5-14.
40. Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, Wee JJ, Wang BZ, Cho YK, Compans RW et al. Protective effect of ginseng polysaccharides on infl uenza viral infection. PLoS One 2012;7:e33678.
41. Qu DF, Yu HJ, Liu Z, Zhang DF, Zhou QJ, Zhang HL, Du AF. Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Vet Parasitol 2011;179:28-34.
42. Sumiyoshi M, Sakanaka M, Kimura Y. Effects of red ginseng extract on allergic reactions to food in Balb/c mice. J Ethnopharmacol 2010;132:206-212.
43. Behrens G, Li M, Smith CM, Belz GT, Mintern J, Car-bone FR, Heath WR. Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol 2004;82:84-90.
44. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002;20:323-370.
45. Berek L, Szabo D, Petri IB, Shoyama Y, Lin YH, Molnar J. Effects of naturally occurring glucosides, solasodine glucosides, ginsenosides and parishin derivatives on mul-tidrug resistance of lymphoma cells and leukocyte functions. In Vivo 2001;15:151-156.
46. Hwang I, Ahn G, Park E, Ha D, Song JY, Jee Y. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Immunol Lett 2011;138:169-178.
47. Lee EJ, Ko E, Lee J, Rho S, Ko S, Shin MK, Min BI, Hong MC, Kim SY, Bae H. Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation. Int Immunopharmacol 2004;4:235-244.
48. Seo N, Hayakawa S, Tokura Y. Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells. Semin Cancer Biol 2002;12:291-300.
49. Alfano M, Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol Immunol 2005;42:161-182.
50. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
51. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
52. Liou CJ, Huang WC, Tseng J. Short-term oral administration of ginseng extract induces type-1 cytokine production. Immunopharmacol Immunotoxicol 2006;28:227-240.
53. Kim KH, Lee YS, Jung IS, Park S Y, Chung HY, Lee IR, Yun YS. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998;64:110-115.
54. Ahn JY, Song JY, Yun YS, Jeong G, Choi IS. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute infl ammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol 2006;46:187-197.
55. Park JS, Shin JA, Jung JS, Hyun JW, Van Le TK, Kim DH, Park EM, Kim HS. Anti-infl ammatory mechanism of compound K in activated microglia and its neuroprotec-tive effect on experimental stroke in mice. J Pharmacol Exp Ther 2012;341:59-67.
56. Kim TW, Joh EH, Kim B, Kim DH. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. Int Immunopharmacol 2012;12:110-116.
57. Kim HA, Kim S, Chang SH, Hwang HJ, Choi YN. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int Immunopharmacol 2007;7:1286-1291.
58. Nakaya TA, Kita M, Kuriyama H, Iwakura Y, Imanishi J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interferon Cytokine Res 2004;24:93-100.
59. Ahn J Y, Choi IS, Shim JY, Yun EK, Yun YS, Jeong G, Song JY. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol 2006;36:37-45.
60. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
61. Han SK, Song JY, Yun YS, Yi SY. Ginsan improved Th1 immune response inhibited by gamma radiation. Arch Pharm Res 2005;28:343-350.
62. Larsen MW, Moser C, Hoiby N, Song Z, Kharazmi A. Ginseng modulates the immune response by induction of interleukin-12 production. APMIS 2004;112:369-373.
63. Lee JH, Han Y. Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell. Int Immunopharmacol 2006;6:1424-1430.
64. Song Z, Moser C, Wu H, Faber V, Kharazmi A, Hoiby N. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection. J Cyst Fibros 2003;2:112-119.
65. Rivera E, Ekholm Pettersson F, Inganas M, Paulie S, Gronvik KO. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005;23: 5411-5419.
66. Yang Z, Chen A, Sun H, Ye Y, Fang W. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine 2007;25:161-169.
67. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
68. Nagy G, Clark JM, Buzas EI, Gorman CL, Cope AP. Nitric oxide, chronic infl ammation and autoimmunity. Immunol Lett 2007;111:1-5.
69. Manzo A, Bombardieri M, Humby F, Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from infl ammation to autoimmunity and tissue damage/remodeling. Immunol Rev 2010;233:267-285.
70. Kim DY, Yang WM. Panax ginseng ameliorates airway inflammation in an ovalbumin-sensitized mouse allergic asthma model. J Ethnopharmacol 2011;136:230-235.
71. Oyagi A, Ogawa K, Kakino M, Hara H. Protective effects of a gastrointestinal agent containing Korean red ginseng on gastric ulcer models in mice. BMC Complement Al-tern Med 2010;10:45.
72. Babayigit A, Olmez D, Karaman O, Bagriyanik HA, Yilmaz O, Kivcak B, Erbil G, Uzuner N. Ginseng ameliorates chronic histopathologic changes in a murine model of asthma. Allergy Asthma Proc 2008;29:493-498.
73. Lim YJ, Na HS, Yun YS, Choi IS, Oh JS, Rhee JH, Cho BH, Lee HC. Suppressive effects of ginsan on the development of allergic reaction in murine asthmatic model. Int Arch Allergy Immunol 2009;150:32-42.
74. Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 2012;202:342-351.
75. Chang SH, Choi Y, Park JA, Jung DS, Shin J, Yang JH, Ko SY, Kim SW, Kim JK. Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model. Clin Nutr 2007;26:785-791.
76. Kim KR, Chung TY, Shin H, Son SH, Park KK, Choi JH, Chung WY. Red ginseng saponin extract attenuates murine collagen-induced arthritis by reducing pro-inflammatory responses and matrix metalloproteinase-3 expression. Biol Pharm Bull 2010;33:604-610.
77. Bae EA, Han MJ, Shin YW, Kim DH. Inhibitory effects of Korean red ginseng and its genuine constituents gin-senosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol Pharm Bull 2006;29:1862-1867.
78. Hong CE, Lyu S Y. Anti-inflammatory and anti-oxidative effects of Korean red ginseng extract in human keratinocytes. Immune Netw 2011;11:42-49.
79. Samukawa K, Izumi Y, Shiota M, Nakao T, Osada-Oka M, Miura K, Iwao H. Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models. J Pharmacol Sci 2012;118:391-400.
80. Lee JH, Cho SH. Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol 2011;133:810-817.
81. Park HJ, Byeon HE, Choi KW, Rhee DK, Lee KR, Pyo SN. Inhibitory effects of ginsenoside Rb1 on atopic dermatitis-like skin lesions in mice. J Ginseng Res 2010;34: 363-368.
82. Lee KG, Son SW. Efficacy of Korean red ginseng in the treatment of atopic dermatitis. J Ginseng Res 2011;35: 149-154.
83. Gonzalez-Lamothe R, Mitchell G, Gattuso M, Diarra MS, Malouin F, Bouarab K. Plant antimicrobial agents and their effects on plant and human pathogens. Int J Mol Sci 2009;10:3400-3419.
84. Song ZJ, Johansen HK, Faber V, Hoiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 1997;105:438-444.
85. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, Hoiby N. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeru-ginosa pneumonia in rats. Antimicrob Agents Chemother 1997;41:961-964.
86. Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell 2006;124:715-727.
87. Lee JH, Shim JS, Chung MS, Lim ST, Kim KH. Inhibition of pathogen adhesion to host cells by polysaccha-rides from Panax ginseng. Biosci Biotechnol Biochem 2009;73:209-212.
88. Lee JH, Shim JS, Lee JS, Kim MK, Chung MS, Kim KH. Pectin-like acidic polysaccharide from Panax ginseng with selective antiadhesive activity against pathogenic bacteria. Carbohydr Res 2006;341:1154-1163.
89. Fukuyama N, Shibuya M, Orihara Y. Antimicrobial poly-acetylenes from Panax ginseng hairy root culture. Chem Pharm Bull (Tokyo) 2012;60:377-380.
90. Lee JH, Park EK, Uhm CS, Chung MS, Kim KH. Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. Planta Med 2004;70:615-619.
91. Park S, Yeo M, Jin JH, Lee KM, Jung JY, Choue R, Cho SW, Hahm KB. Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig Dis Sci 2005;50:1218-1227.
92. Song Z, Johansen HK, Moser C, Høiby N. Effects of Chinese medicinal herbs on a rat model of chronic Pseudo-monas aeruginosa lung infection. APMIS 1996;104:350-354.
93. Song Z, Kong KF, Wu H, Maricic N, Ramalingam B, Priestap H, Schneper L, Quirke JM, Hoiby N, Mathee K. Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection. Phytomedicine 2010;17:1040-1046.
94. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22:65-72.
95. Chan LY, Kwok HH, Chan RW, Peiris MJ, Mak NK, Wong RN, Chan MC, Yue PY. Dual functions of gin-senosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis. J Ethnopharmacol 2011;137:1542-1546.
96. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF. Human infection with infl uenza H9N2. Lancet 1999;354:916-917.
97. Kim J Y, Kim HJ, Kim HJ. Effect of oral administration of Korean red ginseng on infl uenza A (H1N1) virus infection. J Ginseng Res 2011;35:104-110.
98. Quan FS, Compans RW, Cho YK, Kang SM. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 2007;25:272-282.
99. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009;60:471-484.
100. Weiss RA. How does HIV cause AIDS? Science 1993; 260:1273-1279.
101. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
102. Sung H, Jung YS, Cho YK. Beneficial effects of a combination of Korean red ginseng and highly active antiret-roviral therapy in human immunodeficiency virus type 1-infected patients. Clin Vaccine Immunol 2009;16:1127-1131.
103. Geffin R, Wolf D, Muller R, Hill MD, Stellwag E, Freitag M, Sass G, Scott GB, Baur AS. Functional and structural deffects in HIV type 1 nefgenes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses 2000;16:1855-1868.
104. Cho YK, Jung YS, Sung H. Frequent gross deletion in the HIV type 1 nef gene in hemophiliacs treated with Korean red ginseng: inhibition of detection by highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2009;25:419-424.
105. Cho YK, Lim JY, Jung YS, Oh SK, Lee HJ, Sung H. High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng. Curr HIV Res 2006;4:447-457.
106. Cho YK, Jung YS. Dosage and duration effects of Korean red ginseng intake on frequency of gross deletions in the nef gene. J Ginseng Res 2010;34:219-226.
107. Cho YK, Jung YS, Sung H, Sim MK, Kim YK. High frequency of gross deletions in 5' LTR/gag and nef genes in patients infected with CRF02_AG of HIV type 1 who survived for over 20 years: an association with Korean red ginseng. AIDS Res Hum Retroviruses 2009;25:535-541.
108. Cho YK, Jung YJ, Sung HS, Joo CH. Frequent genetic deffects in the HIV-1 5'LTR/gag gene in hemophiliacs treated with Korean red ginseng: decreased detection of genetic deffects by highly active antiretroviral therapy. J Ginseng Res 2011;35:413-420.
109. Cho YK, Jung YS. High frequency of gross deletions in the 5' LTR and gag regions in HIV type 1-infected long-term survivors treated with Korean red ginseng. AIDS Res Hum Retroviruses 2008;24:181-193.
110. Lee MH, Lee BH, Jung JY, Cheon DS, Kim KT, Choi CS. Antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivi-rus as surrogates for human norovirus. J Ginseng Res 2011;35:429-435.
111. Bae EA, Shin JE, Park SH, Kim DH. Inhibitory effect of ginseng polysaccharides on rotavirus infection. J Micro-biol Biotechnol 2004;14:202-204.
112. O'Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003;2:727-735.
113. McElrath MJ. Selection of potent immunological adjuvants for vaccine construction. Semin Cancer Biol 1995;6:375-385.
114. Singh M, O'Hagan DT. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 2003;33:469-478.
115. Song X, Hu S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009;27:4883-4890.
116. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.
117. Sun J, Hu S, Song X. Adjuvant effects of protopanaxa-diol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 2007;25:1114-1120.
118. Song X, Chen J, Sakwiwatkul K, Li R, Hu S. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Int Immunopharmacol 2010;10:351-356.
119. Song X, Zang L, Hu S. Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine 2009;27:2306-2311.
120. Su F, Yuan L, Zhang L, Hu S. Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway. Vaccine 2012;30:4106-4112.
121. Sun J, Song X, Hu S. Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice. Clin Vaccine Immunol 2008;15:303-307.